Trials / Unknown
UnknownNCT05364060
COVID-19 and Mental Health in Eure
Assessment of Severe Depression Related to Psychotrauma in the COVID-19 Context in Patients Followed in Psychiatry in the Department of Eure
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 585 (estimated)
- Sponsor
- Centre Hospitalier Eure-Seine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Research Hypothesis: Living conditions during COVID-19, and lockdowns and curfews impact the psychological state of patients (assessed by the degree of depression, positive and negative thoughts, insomnia, state of post-traumatic stress).
Detailed description
From the early stages of the COVID-19 pandemic, concerns were raised about its effect on mental health and on patients with mental illness. Several surveys and cross-sectional assessments, in Italy, England, Ecuador and China in 2020, have suggested that patients with COVID-19 have symptoms of anxiety (including stress disorder traumatic, depression and insomnia. In France, a survey by "Santé Publique France" on the impact of COVID-19 on mental health carried out in November 2020, revealed a 20% rate of depressive symptoms in the general population. The objective of this study is to assess the level of psychological distress and the prevalence of psychiatric disorders related to COVID-19 as part of the follow-up of psychiatric patients in the department of Eure since March 2020, which has coincided with the onset of the health crisis, including consecutive lockdowns and curfews.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires | Different questionnaires detailed in the objectives part |
Timeline
- Start date
- 2022-06-13
- Primary completion
- 2023-06-13
- Completion
- 2023-06-13
- First posted
- 2022-05-06
- Last updated
- 2022-11-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05364060. Inclusion in this directory is not an endorsement.